Spectral AI, Inc. (MDAI)
| Market Cap | 52.78M-31.1% |
| Revenue (ttm) | 15.39M |
| Net Income | -10.09M |
| EPS | -0.32 |
| Shares Out | 32.18M |
| PE Ratio | n/a |
| Forward PE | -1.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,686 |
| Open | 1.65 |
| Previous Close | 1.66 |
| Day's Range | 1.61 - 1.68 |
| 52-Week Range | 1.18 - 2.97 |
| Beta | 1.21 |
| Analysts | none |
| Price Target | 5.11(+211.79%) |
| Earnings Date | Nov 10, 2026 |
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About MDAI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.
$MDAI stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MDAI holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MDAI's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MDAI Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MDAI Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Amount received from contract | $31.70M | 76.57% |
| Development costs | $9.70M | 23.43% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MDAI patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MDAI from public contracts
Source: USAspending.gov
MDAI Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MDAI’s recent data — informational, not investment advice